• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Al-Azhar Dental Journal for Girls
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 10 (2023)
Volume Volume 9 (2022)
Volume Volume 8 (2021)
Volume Volume 7 (2020)
Volume Volume 6 (2019)
Volume Volume 5 (2018)
Volume Volume 4 (2017)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 3 (2016)
Habba, D., Abo Hager, E., Shouman, A. (2017). Podoplanin Protein Expression in Some Benign and Malignant Variants of Ameloblastoma (An immunohistochemical study). Al-Azhar Dental Journal for Girls, 4(4), 331-338. doi: 10.21608/adjg.2017.5280
Doaa Habba; Eman Abo Hager; Adel Shouman. "Podoplanin Protein Expression in Some Benign and Malignant Variants of Ameloblastoma (An immunohistochemical study)". Al-Azhar Dental Journal for Girls, 4, 4, 2017, 331-338. doi: 10.21608/adjg.2017.5280
Habba, D., Abo Hager, E., Shouman, A. (2017). 'Podoplanin Protein Expression in Some Benign and Malignant Variants of Ameloblastoma (An immunohistochemical study)', Al-Azhar Dental Journal for Girls, 4(4), pp. 331-338. doi: 10.21608/adjg.2017.5280
Habba, D., Abo Hager, E., Shouman, A. Podoplanin Protein Expression in Some Benign and Malignant Variants of Ameloblastoma (An immunohistochemical study). Al-Azhar Dental Journal for Girls, 2017; 4(4): 331-338. doi: 10.21608/adjg.2017.5280

Podoplanin Protein Expression in Some Benign and Malignant Variants of Ameloblastoma (An immunohistochemical study)

Article 1, Volume 4, Issue 4, October 2017, Page 331-338  XML PDF (366.05 K)
Document Type: Original Article
DOI: 10.21608/adjg.2017.5280
Authors
Doaa Habba1; Eman Abo Hager2; Adel Shouman2
1Demonstrator of Oral and Dental Pathology, Faculty of Dental Medicine for Girls, Al Azhar University.
2Professor of Oral and Dental Pathology, Faculty of Dental Medicine for Girls, Al Azhar University
Abstract
Aim: The aim of this study was to evaluate immunohistochemical expression of podoplanin among some benign and malignant variants of ameloblastoma. Material and methods: Thirty seven benign ameloblastoma (AB) tumors were
collected, (six cases of follicular AB, three cases of acanthomatous AB, four cases of granular AB, three cases of basal cell AB and seven cases of plexiform pattern AB), three cases of desmoplastic AB, four cases of peripheral AB and seven cases of unicystic AB (three cases of luminal, two cases of intraluminal and two cases of mural) and eighteen malignant variants of ameloblastoma tumors were collected as paraffin embedded blocks. Immunohistochemical investigation using podoplanin antibody was done for all specimens. Results: The mean area percent of immunoexpression was greatest in
malignant variants of ameloblastoma, followed by benign variants of ameloblastoma tumors and the least value recorded in acanthomatous ameloblastoma. The mean area percent of immunoexpression was greater in plexiform ameloblastoma in comparison to follicular ameloblastoma. The mean area percent of immunoexpression was greatest in ameloblastic carcinoma. Conclusions: Podoplanin is associated with the malignant transformation risk and is a potent biomarker for risk assessment in oral malignant transformation. 
Keywords
Podoplanin; Immunohistochemistry; ameloblastoma variants
Statistics
Article View: 1,140
PDF Download: 388
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.